CN113456668A - 一种女性外用软膏及其制备方法 - Google Patents

一种女性外用软膏及其制备方法 Download PDF

Info

Publication number
CN113456668A
CN113456668A CN202110585026.7A CN202110585026A CN113456668A CN 113456668 A CN113456668 A CN 113456668A CN 202110585026 A CN202110585026 A CN 202110585026A CN 113456668 A CN113456668 A CN 113456668A
Authority
CN
China
Prior art keywords
parts
tablets
portions
ointment
nystatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110585026.7A
Other languages
English (en)
Inventor
齐万琴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110585026.7A priority Critical patent/CN113456668A/zh
Publication of CN113456668A publication Critical patent/CN113456668A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/22Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/28Mercury; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种女性外用软膏,包括甲硝唑片8‑12份、制霉菌素片8‑12份、氯雷他定片8‑12份、扑尔敏8‑12份、冰硼散13‑17份和肤轻松乳膏103‑107份。本发明属于医药技术领域,具体是一种女性外用软膏及其制备方法,取之于专门治疗妇科疾病药物之精华,归结一处药效,一药多效,价格适当使用方便,直达病处,疗效快。

Description

一种女性外用软膏及其制备方法
技术领域
本发明属于医药技术领域,具体是指一种女性外用软膏及其制备方法。
背景技术
女性外阴炎、阴道炎、宫颈糜烂、子宫内膜炎、附件炎;霉菌、滴虫所致瘙痒、渗出、出血、疼痛等症是临床妇科炎症的多见症状,常见的方法是通过中医采取清热解毒、利湿化浊、凉血止血的手段对其进行治疗。但实践中,由于许多中药具有起效慢、疗程长、使用不方便等缺点,严重影响其临床应用。
发明内容
针对上述情况,为克服现有技术的缺陷,本发明提供一种女性外用软膏及其制备方法,取之于专门治疗妇科疾病药物之精华,归结一处药效,一药多效,价格适当使用方便,直达病处,疗效快;可进行杀菌、杀虫、霉菌性阴道炎、细菌性阴道炎、荨麻疹、湿疹、皮炎、神经性皮炎、皮肤瘙痒的治疗;缓解由细菌引起阴道炎疾病;滴虫性阴道炎所致的阴道分泌物异常、异味,慢性粘膜皮肤念珠菌病;皮肤过敏症、荨麻疹、湿疹、皮炎、皮肤瘙痒、神经性皮炎;缓解疼痛、清热解毒、消肿止痛、溃疡糜烂。
本发明采取的技术方案如下:本发明一种女性外用软膏,包括甲硝唑片8-12份、制霉菌素片8-12份、氯雷他定片8-12份、扑尔敏8-12份、冰硼散13-17份和肤轻松乳膏103-107份。
进一步地,包括甲硝唑片9-11份、制霉菌素片9-11份、氯雷他定片9-11份、扑尔敏9-11份、冰硼散14-16份和肤轻松乳膏104-106份。
进一步地,包括甲硝唑片10份、制霉菌素片10份、氯雷他定片10份、扑尔敏10份、冰硼散15和肤轻松乳膏105份。
本发明一种女性外用软膏的制备方法,包括如下步骤:
1)将甲硝唑、制霉菌片、氯雷他定或扑尔敏碾制成粉末;
2)加入冰硼散和肤轻松乳膏一起搅拌一体,变成粘状即成药合成。
采用上述结构本发明取得的有益效果如下:本方案一种女性外用软膏及其制备方法,取之于专门治疗妇科疾病药物之精华,归结一处药效,一药多效,价格适当使用方便,直达病处,疗效快;可进行杀菌、杀虫、霉菌性阴道炎、细菌性阴道炎、荨麻疹、湿疹、皮炎、神经性皮炎、皮肤瘙痒的治疗;缓解由细菌引起阴道炎疾病;滴虫性阴道炎所致的阴道分泌物异常、异味,慢性粘膜皮肤念珠菌病;皮肤过敏症、荨麻疹、湿疹、皮炎、皮肤瘙痒、神经性皮炎;缓解疼痛、清热解毒、消肿止痛、溃疡糜烂。
具体实施方式
下面将结合本发明实施例,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例;基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明一种女性外用软膏,包括甲硝唑片8-12份、制霉菌素片8-12份、氯雷他定片8-12份、扑尔敏8-12份、冰硼散13-17份和肤轻松乳膏103-107份。
包括甲硝唑片9-11份、制霉菌素片9-11份、氯雷他定片9-11份、扑尔敏9-11份、冰硼散14-16份和肤轻松乳膏104-106份。
包括甲硝唑片10份、制霉菌素片10份、氯雷他定片10份、扑尔敏10份、冰硼散15和肤轻松乳膏105份。
本发明一种女性外用软膏的制备方法,包括如下步骤:
1)将甲硝唑、制霉菌片、氯雷他定或扑尔敏碾制成粉末;
2)加入冰硼散和肤轻松乳膏一起搅拌一体,变成粘状即成药合成。
具体使用时,用户将该药膏置于阴道中,一次使用15克,连续使用七天为一个疗程,早晚各用一次,严重者听医嘱,孕妇禁用,以上便是本发明整体的工作流程,下次使用时重复此步骤即可。
需要说明的是,在本文中,诸如第一和第二等之类的关系术语仅仅用来将一个实体或者操作与另一个实体或操作区分开来,而不一定要求或者暗示这些实体或操作之间存在任何这种实际的关系或者顺序。而且,术语“包括”、“包含”或者其任何其他变体意在涵盖非排他性的包含,从而使得包括一系列要素的过程、方法、物品或者设备不仅包括那些要素,而且还包括没有明确列出的其他要素,或者是还包括为这种过程、方法、物品或者设备所固有的要素。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
以上对本发明及其实施方式进行了描述,这种描述没有限制性,只是本发明的实施方式之一,并不局限于此。总而言之如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性的设计出与该技术方案相似的结构方式及实施例,均应属于本发明的保护范围。

Claims (4)

1.一种女性外用软膏,其特征在于;包括甲硝唑片8-12份、制霉菌素片8-12份、氯雷他定片8-12份、扑尔敏8-12份、冰硼散13-17份和肤轻松乳膏103-107份。
2.根据权利要求1所述的一种女性外用软膏,其特征在于;包括甲硝唑片9-11份、制霉菌素片9-11份、氯雷他定片9-11份、扑尔敏9-11份、冰硼散14-16份和肤轻松乳膏104-106份。
3.根据权利要求2所述的一种女性外用软膏,其特征在于;包括甲硝唑片10份、制霉菌素片10份、氯雷他定片10份、扑尔敏10份、冰硼散15和肤轻松乳膏105份。
4.一种女性外用软膏的制备方法,其特征在于;包括如下步骤:
1)将甲硝唑、制霉菌片、氯雷他定或扑尔敏碾制成粉末;
2)加入冰硼散和肤轻松乳膏一起搅拌一体,变成粘状即成药合成。
CN202110585026.7A 2021-05-27 2021-05-27 一种女性外用软膏及其制备方法 Pending CN113456668A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110585026.7A CN113456668A (zh) 2021-05-27 2021-05-27 一种女性外用软膏及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110585026.7A CN113456668A (zh) 2021-05-27 2021-05-27 一种女性外用软膏及其制备方法

Publications (1)

Publication Number Publication Date
CN113456668A true CN113456668A (zh) 2021-10-01

Family

ID=77871564

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110585026.7A Pending CN113456668A (zh) 2021-05-27 2021-05-27 一种女性外用软膏及其制备方法

Country Status (1)

Country Link
CN (1) CN113456668A (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492917A (en) * 1975-05-17 1977-11-23 Bayer Ag Granules and powders for the preparation of ointments
CN1562003A (zh) * 2004-03-16 2005-01-12 白宏臣 复方甲硝唑乳膏
CN106619741A (zh) * 2016-12-28 2017-05-10 河南八灵电子科技有限公司 一种用于治疗湿疹的药物及其制备方法
CN106668864A (zh) * 2016-10-19 2017-05-17 毕明华 一种治疗皮肤病的外用药膏
CN108524537A (zh) * 2018-06-27 2018-09-14 赵怀邦 一种炎净散软膏

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1492917A (en) * 1975-05-17 1977-11-23 Bayer Ag Granules and powders for the preparation of ointments
CN1562003A (zh) * 2004-03-16 2005-01-12 白宏臣 复方甲硝唑乳膏
CN106668864A (zh) * 2016-10-19 2017-05-17 毕明华 一种治疗皮肤病的外用药膏
CN106619741A (zh) * 2016-12-28 2017-05-10 河南八灵电子科技有限公司 一种用于治疗湿疹的药物及其制备方法
CN108524537A (zh) * 2018-06-27 2018-09-14 赵怀邦 一种炎净散软膏

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
刘新兰等: "肤轻松制霉菌素甲硝唑在妇科疾病中的协同使用", 《安庆医学》 *
王昱霖: "甲硝唑片混合冰硼散配伍康妇消炎栓治疗慢性宫颈炎的临床分析", 《中国农村卫生》 *
王燕 等: ""制霉菌素联合冰硼散阴道上药治疗单纯性假丝酵母菌性阴道炎的临床观察"", 《基层医学论坛》 *
陈冰心: ""制霉菌素配伍冰硼散加减治疗念珠菌性阴道病"", 《浙江中西医结合杂志》 *

Similar Documents

Publication Publication Date Title
CN101810642B (zh) 一种治疗口腔溃疡和急性扁桃体炎的中药制剂及制备方法
CN101744976B (zh) 一种杀菌止痒的洗剂及其制备方法
CN104096163A (zh) 用于女性卵巢及内外阴养护保洁的外用药剂
CN104147108A (zh) 含有褐藻寡糖的抑菌凝胶
CN103800510B (zh) 一种外用洗液组方及制备方法
CN113456668A (zh) 一种女性外用软膏及其制备方法
CN110623993A (zh) 治疗妇科炎症的中药组合物的复合营养片及其制备方法
CN103239676A (zh) 一种用于防治细菌性阴道病的外用药物组合物
CN103182043A (zh) 一种治疗妇科炎症的外用中药及其制备方法
CN110302273A (zh) 一种中药抑菌凝胶及其制备方法和应用
CN102485247B (zh) 一种治疗妇科疾病的中药组合物及其制备方法
CN106728166A (zh) 治疗湿疹皮炎的中药组合物
CN101919899B (zh) 一种洁阴护理品
CN102247490A (zh) 一种强效皮伤炎乳膏及其制作方法
CN105168503B (zh) 一种用于防治放射性皮炎的外用中药组合物及其制备方法
CN1174770C (zh) 治疗妇科炎症的外用药物及其制备方法
CN110664934B (zh) 抗菌止痒的中药组合物及其制备方法和应用
CN1049145C (zh) 妇女专用消毒液
CN103536706B (zh) 一种治疗妊娠期念珠菌性阴道炎的中药薰洗剂
CN116898940B (zh) 非哺乳期乳腺炎早期治疗的中药组合物及其制备方法
CN102872202B (zh) 一种中老年妇女阴部护理油膏及其制备方法
CN115607592A (zh) 复方虎杖湿润烧伤膏及其制备方法
Gv et al. An integrative ayurvedic approach in management of breast abscess–A case report
CN113750152A (zh) 一种护理阴道松弛的外用配方
CN106266458B (zh) 一种治疗银屑病及神经性皮炎疾病的中药组合物及其应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20211001